Extracorporeal Membrane Oxygenation Market - By Modality (Venoarterial, Veno-venous, Arteriovenous), By Application (Cardiac, Respiratory, Extracorporeal Cardiopulmonary Resuscitation), By Patient Population (Infant, Pediatric, Adult) & Global Forecast, 2023 – 2032

Extracorporeal Membrane Oxygenation Market - By Modality (Venoarterial, Veno-venous, Arteriovenous), By Application (Cardiac, Respiratory, Extracorporeal Cardiopulmonary Resuscitation), By Patient Population (Infant, Pediatric, Adult) & Global Forecast, 2023 – 2032

Extracorporeal Membrane Oxygenation Market Size

Extracorporeal Membrane Oxygenation Market size was valued at more than USD 490 million in 2022 and is poised to register over 3.4% CAGR between 2023 and 2032.
 

Extracorporeal membrane oxygenation is also known as extracorporeal life support. It is a life-supporting system that provides respiratory and cardiac support to the patients suffering from severe respiratory failure. Increasing awareness among patients regarding the importance of cardiopulmonary assistance for severe cardiac and respiratory conditions, thereby will accelerate the adoption rate of ECMO therapy.

Growing adoption of unhealthy habits such as excessive smoking, tobacco consumption, and alcohol consumption contribute to the existing burden of lung diseases. Moreover, a large patient population base is suffering from lung and heart diseases in highly populated countries such as China and India. This is expected to offer numerous industry growth opportunities in these countries.

Extracorporeal Membrane Oxygenation Market Trends

A momentous rise in the prevalence of cardiovascular and respiratory disorders has been observed in past few years in the European region and the trend is projected to continue over the coming years. Increasing number of CVD cases resulted in increasing government initiatives and introduction of various programs in the region in order to increase awareness among people. For instance, the Public Health England (PHE) organization is actively involved in major initiatives to support improvements in CVD prevention and reduction. PHE organization works with local partners and provides information regarding advanced therapies and devices including ECMO devices for treating CVD.
 

Extracorporeal Membrane Oxygenation Market Analysis

Extracorporeal membrane oxygenation market from veno-arterial (VA) segment held more than USD 220 million in 2022 and is anticipated to reach over USD 290 million by 2032. This is due to its widespread application in treating patients suffering from cardiac arrest, pulmonary embolism, pulmonary hypertension, and other diseases. Therefore, growing applications and product adoption will stimulate the demand for veno-arterial extracorporeal membrane oxygenation.
 

Respiratory segment dominated the ECMO market accounting for more than 65% business share in 2022. The risk of respiratory failure among patients suffering from various respiratory disorders is a major contributor to segment growth. Additionally, expanding geriatric population base prone to suffer from respiratory illnesses is said to stimulate the market landscape.
 

Extracorporeal membrane oxygenation market from paediatric segment was valued at over USD 100 million in 2022 is anticipated to reach more than 135 million by 2032. The device is used to treat diverse types of diseases in children, including meconium aspiration syndrome, pneumonia, congenital diaphragmatic hernia (CDH), and respiratory distress syndrome (RDS).
 

North America extracorporeal membrane oxygenation market accounted for more than 59% in 2022. This is driven by well-developed healthcare infrastructure, rising prevalence of pulmonary diseases and expanding geriatric population base. The regional growth is further enhanced by the presence of a highly developed co-payment and insurance system along with presence of established industry players in the region.
 

Extracorporeal Membrane Oxygenation Market Share

The global extracorporeal membrane oxygenation market consists of several players including

• Abbott Laboratories
• Fresenius Medical Care AG & Co
• KGaA
• Braile Biomedica
• Edwards Lifesciences Corporation
• Abiomed
• Eurosets
• Getinge AB
• LivaNova PLC
• Medtronic
• MicroPort Scientific Corporation
• Nipro
• SB-Kawasumi Laboratories Inc
• Spectrum Medical,
• Terumo Corporation
   

Extracorporeal membrane oxygenation market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Modality

• Venoarterial
• Veno-venous
• Arterio-venous

By Application

• Cardiac
• Respiratory
• Extracorporeal cardiopulmonary resuscitation (ECPR)

By Patient Population

• Infant
• Pediatric
• Adult

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Qatar
  • UAE